Using antibodies, small-molecule inhibitors, or small hairpin RNA in glioma tumors in mouse xenograft models, several groups have reported that PTPRZ is a promising therapeutic target for glioma (19, 20, 31). The gene discussed is PTPRZ1; the disease is central nervous system cancer.